110 related articles for article (PubMed ID: 11955646)
1. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
[TBL] [Abstract][Full Text] [Related]
2. L-myc genotype is associated with different susceptibility to lung cancer in smokers.
Kumimoto H; Hamajima N; Nishimoto Y; Matsuo K; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2002 Jan; 93(1):1-5. PubMed ID: 11802801
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
5. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
6. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
[TBL] [Abstract][Full Text] [Related]
8. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
[TBL] [Abstract][Full Text] [Related]
9. A new polymorphism (Ser362Thr) of the L-myc gene is not associated with lung adenocarcinoma risk and prognosis.
Spinola M; Conti B; Ravagnani F; Fabbri A; Incarbone M; Cataldo I; Pira E; Pelucchi C; La Vecchia C; Dragani TA
Eur J Cancer Prev; 2004 Feb; 13(1):87-9. PubMed ID: 15075794
[TBL] [Abstract][Full Text] [Related]
10. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
[TBL] [Abstract][Full Text] [Related]
11. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
Tefre T; Børresen AL; Aamdal S; Brøgger A
Br J Cancer; 1990 Jun; 61(6):809-12. PubMed ID: 1973618
[TBL] [Abstract][Full Text] [Related]
12. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
13. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
14. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
[TBL] [Abstract][Full Text] [Related]
15. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
16. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk.
Gu J; Spitz MR; Yang F; Wu X
Carcinogenesis; 1999 Aug; 20(8):1465-9. PubMed ID: 10426793
[TBL] [Abstract][Full Text] [Related]
17. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
[TBL] [Abstract][Full Text] [Related]
19. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
20. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
